CAS RN: 1197205-71-2

4Z,7Z,10Z,13Z,16Z,19Z-DOCOSAHEXAENOIC-21,21,22,22,22-D5 ACID

Product Availability

Choose a grade to view its available package options.

1 package records0 with current stock1 grade group
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20251209 1mg Out of stock 5-7 business days Inquiry
  • Product code: starshine_CAS1197205-71-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1197205-71-2 / (4Z,7Z,10Z,13Z,16Z,19Z)-21,21,22,22,22-pentadeuteriodocosa-4,7,10,13,16,19-hexaenoic acid

DOCOSA-4,7,10,13,16,19-HEXAENOIC ACID | cis-4,7,10,13,16,19-Docosahexaenoic acid | 4,7,10,13,16,19-Docosahexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)-

Standard CAS: 1197205-71-2 Multi CAS: Yes

Basic Information

CAS
1197205-71-2
Multi CAS
Yes
Molecular Formula
C22H32O2
Molecular Weight
333.500000
Exact Mass
333.271614
SMILES
[2H]C([2H])([2H])C([2H])([2H])/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O
InChI
InChI=1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-/i1D3,2D2
InChIKey
MBMBGCFOFBJSGT-RPBOKJFVSA-N
Synonyms
DOCOSA-4,7,10,13,16,19-HEXAENOIC ACID cis-4,7,10,13,16,19-Docosahexaenoic acid 4,7,10,13,16,19-Docosahexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)- DHA;Cervonic Acid CBiol_001946

Computed Properties

Structural Parameters

Heavy atom count
24
Fraction Csp3
0.41
Rotatable bonds
14
H-bond acceptors
1
H-bond donors
1
Molar refractivity
105.09
TPSA
37.3

LogP / Solubility

WLOGP
6.55
MLOGP
5.78
XLogP3
6.2
Consensus LogP
6.18
Log S (ESOL)
-5.08
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.98
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.91
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-0.07

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2.5

Get In Touch

Contact Us